No, I appreciate that the excerpts you posted are from CYP's corporate governance ann. So it is specific to CYP, but the issue of disclosure under placements and information asymmetry isn't. That CYP corporate governance statement ann is much like clinical trial result anns and an issue I have read you highlight previously - the ann is a summary/generalisation that glosses over some nuance and specifics. In this case it's a general statement of principles, but if you delve into the specifics it contains exceptions. That is a common issue, not just a CYP issue.
CYP's full corporate governance disclosure is here: https://cynata.com/corporate-governance The Continuous Disclosure section alone is a 17 page pdf and notes the exception I posted from the Corporations Regulations in 2.2
- Forums
- ASX - By Stock
- Screenshot(s) from Annual Report of 29 Aug 24
CYP
cynata therapeutics limited
Add to My Watchlist
2.94%
!
16.5¢

No, I appreciate that the excerpts you posted are from CYP's...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.5¢ |
Change
-0.005(2.94%) |
Mkt cap ! $37.28M |
Open | High | Low | Value | Volume |
16.5¢ | 16.5¢ | 16.0¢ | $59.06K | 360.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 88474 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.165 |
4 | 66451 | 0.155 |
4 | 130000 | 0.150 |
2 | 45937 | 0.140 |
1 | 25000 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 88474 | 2 |
0.175 | 77450 | 2 |
0.180 | 113494 | 5 |
0.185 | 35990 | 1 |
0.190 | 8868 | 1 |
Last trade - 13.19pm 19/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
RML
RESOLUTION MINERALS LTD
Craig Lindsay, In-Country CEO
Craig Lindsay
In-Country CEO
SPONSORED BY The Market Online